Tag: Phase Ii Trial Of Oxford Covid 19 Vaccine

Astrazeneca
PGIMER To Begin Phase II Trial Of Oxford Covid-19 Vaccine Candidate

New Delhi: The Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh will be beginning the Phase II trial of oxford Covid-19 vaccine candidate — Covishield from the first week of September. The premier institute has received approval from its internal ethical committee and is awaiting the signing of the tripartite agreement between […]

  • Tuesday, 13 April 2021
scrollToTop